
Samia Ab built and maintained core analytics features for the pharmaverse/aNCA repository, focusing on dose-escalation analysis in R. She addressed a critical bug by refining the subject counting logic in get_dose_esc_results, ensuring that dose escalation summaries accurately reflected unique subjects rather than groups. This targeted fix improved the reliability of early-phase clinical trial data and supported better decision-making for trial design. Samia also managed release packaging by updating the DESCRIPTION file, aligning the project with semantic versioning and CI/CD best practices. Her work demonstrated proficiency in R programming, data manipulation, and package development, with careful attention to code isolation and traceability.
February 2026 monthly summary for pharmaverse/aNCA: Implemented release packaging changes by bumping the package version in DESCRIPTION to reflect the latest changes, preparing the project for the upcoming release. No major bugs fixed during this period. This work improves release stability, reproducibility, and readiness for CI/CD, with clear commit traceability to the release. Technologies demonstrated include R packaging (DESCRIPTION), semantic versioning, and Git-based release management.
February 2026 monthly summary for pharmaverse/aNCA: Implemented release packaging changes by bumping the package version in DESCRIPTION to reflect the latest changes, preparing the project for the upcoming release. No major bugs fixed during this period. This work improves release stability, reproducibility, and readiness for CI/CD, with clear commit traceability to the release. Technologies demonstrated include R packaging (DESCRIPTION), semantic versioning, and Git-based release management.
January 2026: Focused on accuracy improvements in dose-escalation analytics within pharmaverse/aNCA. Implemented a bug fix to ensure distinct subject counting in get_dose_esc_results, improving the reliability of dose escalation summaries used in early-phase analyses. The patch corrects counting from groups to individual subjects (commit 86b764ecd49763d98d3c4a6f37d0b896095add3c) and was integrated with existing aNCA modules, enhancing data integrity with minimal risk. Expected downstream value includes more reliable dose recommendations and better decision support for trial design.
January 2026: Focused on accuracy improvements in dose-escalation analytics within pharmaverse/aNCA. Implemented a bug fix to ensure distinct subject counting in get_dose_esc_results, improving the reliability of dose escalation summaries used in early-phase analyses. The patch corrects counting from groups to individual subjects (commit 86b764ecd49763d98d3c4a6f37d0b896095add3c) and was integrated with existing aNCA modules, enhancing data integrity with minimal risk. Expected downstream value includes more reliable dose recommendations and better decision support for trial design.

Overview of all repositories you've contributed to across your timeline